Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × AP 1903 reagent × Clear all

NCT02744287 2026-02-23

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Phase 1 Terminated

Prostatic Neoplasms